What was Quantum Genesis AI’s price range in the past 12 months?
Quantum Genesis AI lowest stock price was $0.02 and its highest was $5.04 in the past 12 months.
What is Quantum Genesis AI’s market cap?
Quantum Genesis AI’s market cap is $1.43M.
When is Quantum Genesis AI’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Quantum Genesis AI overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Quantum Genesis AI pay dividends?
Quantum Genesis AI does not currently pay dividends.
What is Quantum Genesis AI’s EPS estimate?
Quantum Genesis AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quantum Genesis AI have?
Quantum Genesis AI has 40,972,050 shares outstanding.
Which hedge fund is a major shareholder of Quantum Genesis AI?
Currently, no hedge funds are holding shares in QGAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Quantum Genesis AI
Quantumzyme Corp. operates as a biotransformation company. It develops engineered enzymes for use in active pharmaceutical ingredients production. The company was formerly known as Reliant Services, Inc. and changed its name to Quantumzyme Corp. in March 2023. The company was incorporated in 2015 and is based in San Diego, California.
Sector
Basicmaterials
Industry
Chemicals - Specialty
CEO
Naveen Krishnarao Kulkarni
Employees
0
Website
www.quantumzymecorp.com
Address
15656 Bernardo Center Drive, San Diego, CA, 92127, US